Samit Hirawat

Insider Reports History

Location
Princeton, NJ
Signature
/s/ Kristen Williams, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samit Hirawat:

Company Role Class Num Shares Value Price $ Report Date Ownership
BRISTOL MYERS SQUIBB CO EVP,Chief Med.Offr.,Drug Dev. Common Stock, $0.10 par value 83,513 $3,973,571 $47.58 25 Apr 2025 Direct
BRISTOL MYERS SQUIBB CO EVP,Chief Med.Offr.,Drug Dev. Market Share Units 35,146 $1,862,387 $52.99 10 Mar 2025 Direct
BRISTOL MYERS SQUIBB CO EVP,Chief Med.Offr.,Drug Dev. Performance Shares 52,720 10 Mar 2025 Direct
Pacira BioSciences, Inc. Director Stock Option (Right to Buy) 39,291 27 Jan 2026 Direct

Insider Reports Filed by Samit Hirawat

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PCRX Pacira BioSciences, Inc. 27 Jan 2026 1 $0 4 Director 29 Jan 2026, 16:57
PCRX Pacira BioSciences, Inc. 27 Jan 2026 0 $0 3 Director 29 Jan 2026, 16:50
BMY BRISTOL MYERS SQUIBB CO 25 Apr 2025 1 +$202,215 4 EVP,Chief Med.Offr.,Drug Dev. 29 Apr 2025, 18:14
BMY BRISTOL MYERS SQUIBB CO 10 Mar 2025 18 -$1,013,294 4 EVP,Chief Med.Offr.,Drug Dev. 12 Mar 2025, 21:30
BMY BRISTOL MYERS SQUIBB CO 14 Feb 2025 1 +$100,000 4 EVP,Chief Med.Offr.,Drug Dev. 19 Feb 2025, 19:19
BMY BRISTOL MYERS SQUIBB CO 01 Nov 2024 1 +$100,055 4 EVP,Chief Med.Offr.,Drug Dev. 05 Nov 2024, 17:41
BMY BRISTOL MYERS SQUIBB CO 10 Mar 2024 16 -$734,180 4 EVP,Chief Med.Offr.,Drug Dev. 12 Mar 2024, 20:40
BMY BRISTOL MYERS SQUIBB CO 01 Jul 2023 3 -$306,129 4 EVP,Chief Med.Offr.,Drug Dev. 05 Jul 2023, 17:23
BMY BRISTOL MYERS SQUIBB CO 10 Mar 2023 18 -$1,471,575 4 EVP,Chief Med.Offr.,Drug Dev. 14 Mar 2023, 20:18
BMY BRISTOL MYERS SQUIBB CO 01 Jul 2022 3 -$367,756 4 EVP,Chief Med.Offr.,Drug Dev. 05 Jul 2022, 16:28
BMY BRISTOL MYERS SQUIBB CO 10 Mar 2022 10 -$356,126 4 EVP,Chief Med.Offr.,Drug Dev. 14 Mar 2022, 21:17
BMY BRISTOL MYERS SQUIBB CO 01 Jul 2021 3 -$318,556 4 EVP,Chief Med.Offr.,Drug Dev. 06 Jul 2021, 16:38